Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HSD17B1 antisense RNA 1 (HSD17B1-AS1) is a long non-coding RNA transcribed antisense to the *HSD17B1* gene, which encodes the enzyme 17β-hydroxysteroid dehydrogenase type 1. Antisense RNAs like HSD17B1-AS1 are generally involved in regulatory functions, typically modulating the expression of their sense gene partner via transcriptional interference, mRNA stability, or epigenetic changes. There is no established role for HSD17B1-AS1 as a direct therapeutic target, nor is it well studied in the context of human disease or drug discovery, according to the results provided. Most research and clinical interest is currently focused on the enzymatic protein *HSD17B1*[1][4][7], rather than on its antisense non-coding transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HSD17B1 antisense RNA 1 (HSD17B1-AS1).